Novartis eyes more bolt-on acquisitions, CEO says

Core Viewpoint - Novartis plans to continue pursuing bolt-on acquisitions while maintaining its existing capital allocation priorities, as stated by CEO Vasant Narasimhan at a major industry conference in San Francisco [1] Group 1 - The company is focused on strategic acquisitions to enhance its portfolio [1] - Capital allocation strategies will remain consistent, indicating stability in financial management [1]